Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24
Drug Metabolism and Pharmacokinetics · 2020-12 · 35 (6) · 515-521
DOI: 10.1016/j.dmpk.2020.07.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Pharmacokinetics, 2020-12. Verfasst von Weiyi Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Membrane Transport and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa Unive…. Hauptthemen laut MEDLINE: RNA Processing, Post-Transcriptional. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Human OATP2B1, a member of organic anion transporting polypeptide family, is expressed in several tissues, including small intestine and liver, and contributes to cellular uptake of endogenous compounds and various drugs. Altered expression of OATP2B1 affects pharmacokinetics of substrate drugs; however, limited information is available on the regulation of OATP2B1 expression. This study aimed to explore microRNAs (miRNAs) that regulate OATP2B1 expression using HEK293 cells transfected with an expression plasmid of OATP2B1 including 3'-UTR (HEK/OATP2B1) and Caco-2 as a model of human intestine. Computational analysis predicted that three miRNAs, miR-143, miR-125b and miR-24, may bind to the 3'-UTR of OATP2B1 mRNA. A luciferase assay using a plasmid containing the 3'-UTR of OATP2B1 gene demonstrated that only miR-24 significantly reduced its expression. The overexpression of miR-24 decreased the expression of OATP2B1 mRNA and protein in HEK/OATP2B1 and Caco-2 cells and uptake of [3H]estrone-3-sulfate by HEK/OATP2B1 cells. However, a statistically significant increase of endogenous OATP2B1 expression was not observed by miR-24 inhibitor in Caco-2 cells. In conclusion, it was found that miR-24 negatively regulates OATP2B1 expression, resulting in suppression of OATP2B1 activity, while its contribution to regulation of apparent expression of OATP2B1 is considered to depend on tissues and cell types.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Membrane Transport and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
- Drug Metabolism and Toxicology, Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan; WPI Nano Life Science Institute (WPI-NanoLSI), Kanazawa…
- Membrane Transport and Biopharmaceutics, Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan. Electronic address: tamai@p.kanazawa-u.ac.jp.
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Liu, W., Nakano, M., Nakanishi, T., Nakajima, M., & Tamai, I. (2020). Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24. Drug Metabolism and Pharmacokinetics, 35(6), 515-521. https://doi.org/10.1016/j.dmpk.2020.07.007
Vancouver
Liu W, Nakano M, Nakanishi T, Nakajima M, Tamai I. Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24. Drug Metabolism and Pharmacokinetics. 2020;35(6):515-521. doi:10.1016/j.dmpk.2020.07.007
BibTeX
@article{Liu2020,
author = {Liu, Weiyi and Nakano, Masataka and Nakanishi, Takeo and Nakajima, Miki and Tamai, Ikumi},
title = {Post-transcriptional regulation of OATP2B1 transporter by a microRNA, miR-24},
journal = {Drug Metabolism and Pharmacokinetics},
year = {2020},
volume = {35},
number = {6},
pages = {515--521},
doi = {10.1016/j.dmpk.2020.07.007}
}
EUVIMED